Author:
Hochster H.S.,Grothey A.,Hart L.,Rowland K.,Ansari R.,Alberts S.,Chowhan N.,Ramanathan R.K.,Keaton M.,Hainsworth J.D.,Childs B.H.
Reference20 articles.
1. NCCN Clinical Practice Guidelines in Oncology for Colon Cancer. V.1.2011.
2. N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer;Goldberg;Clin Colorectal Cancer,2002
3. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000
4. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer;Giacchetti;J Clin Oncol,2000
5. Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC);Grothey;Proc Am Soc Clin Oncol,2002
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献